Clinical aspects of the treatment of breast fibroadenomas with high-intensity focused ultrasound (HIFU).

Клинические аспекты лечения фиброаденом молочных желез высокоинтенсивным фокусированным ультразвуком (HIFU).
Zhazira Seidagaliyeva 1, Suyindik Imankulov 2, Turlybek Tuganbekov 1 2, Kulsara Rustemova 1
More Detail
1 JSC “Astana Medical University” Astana, Kazakhstan
2 JSC “National Scientific Medical Research Center”, Astana, Kazakhstan
J CLIN MED KAZ, Volume 1, Issue 35, pp. 6-10.
OPEN ACCESS 3120 Views 2382 Downloads
Download Full Text (PDF)

ABSTRACT

The main method of treatment of fibroadenomas of the mammary glands to date is surgical. Surgery is often accompanied by complications: hematoma, inflammation, divergence joints, pain in the surgery, etc. Introduction of new technologies of minimally invasive alternative to open surgery are laparoscopic surgery; as a large number of studies conducted in the field of laser, cryo -, thermal ablation. But really noninvasive methods of practical medicine are radiation and chemotherapy, both methods have a lot of side effects. At the present time there was the possibility of introducing a new non-invasive method of treatment of breast fibroadenomas:  HIFU-therapy.  Нigh-intensive focused ultrasound (HIFU) has declared itself as a new clinical method for non-invasive local treatment of tumors. The author is given etiology, classification, treatment of breast fibroadenomas, a brief overview of the concept of HIFU-therapy, the mechanism of action HIFU-therapy, HIFU device used for the treatment of mammary tumors, evaluation methods the performance of ablation, the criteria for cure.

CITATION

Seidagaliyeva Z, Imankulov S, Tuganbekov T, Rustemova K. Clinical aspects of the treatment of breast fibroadenomas with high-intensity focused ultrasound (HIFU).. Journal of Clinical Medicine of Kazakhstan. 2015;1(35):6-10.

REFERENCES

  • Dolgih V.T. Opuholevyj rost (Tumor growth), M.: Medicinskaja kniga, 2001, 81 р.
  • Dovgavljuk A.Z. Rak molochnoj zhelezy: jetiologija, klinika, diagnostika, lechenie, voprosy mediko-social’noj jekspertizy i reabilitacii (Breast cancer: etiology, clinical features, diagnosis, treatment, questions of medical and social expertise and rehabilitation), Posobie dlja vrachej, SPb: Mega-print, 2001, 203 p.
  • Plohov V.N. Otdalennye rezul’taty organosberegajushhih operacij pri rake molochnoj zhelezy (Long-term results of organ operations in breast cancer), Onkologija na rubezhe XXI veka. Vozmozhnosti i perspektivy, Sbornik tezisov, M., 1999, pp. 294- 295.
  • Trapeznikov N.N., Aksel’ E.M. Statistika zlokachestvennyh novoobrazovanij v Rossii i stranah SNG (Statistics malignancies in Russia and the CIS), Trapeznikov N.N., Aksel’ E.M., Moskva: RONC im. NN. Blohina, 2001.
  • Bijker N., Peterse J.L., Duchateau L. et al. Risk factors for recurrence and matastasis after breast-conserving therapy for ductal carcinoma in situ, Ahalysis of EORTC trial 10853, EJC, 2000, No. 36 (Suppl. 5), 120 р.
  • Semiglazov V.V. Karcinoma in situ molochnoj zhelezy -morfologicheskie i klinicheskie problemy (Carcinoma in situ breast cancer and clinical problems -morfologicheskie), Prakticheskaja onkologija, 2002, No 3 (1), рр.60-68.
  • Semiglazov V.F., Kanaev S.V., Bugrov L.I. Promezhutochnye rezul’taty randomizirovannogo issledovanija «Ocenka roli adjuvantnoj luchevoj terapii v organosohranjajushhem lechenii raka molochnoj zhelezy» (Interim results of a randomized study «Assessing the role of adjuvant radiotherapy in organ-preserving treatment of breast cancer»), Voprosy onkologii, 1998, No. 4, pp. 436-439.
  • Chajka V.K. Molochnaja zheleza ot 0 do 18 (The mammary gland is from 0 to 18), V.K. Chajka, M.Ju. Sergeenko, S.A. Lasachko, Doneck: Al’mateo, 2006, 120 p.
  • Kampovoj-Polevoj E.B., Chistjakov S.S. Klinicheskaja mammologija (Clinical mammalogy), Moskva 2006,141 p.
  • Pennes HH. Analysis of tissue and arterial blood temperatures in the resting human forearm, J Appl Physiol, 1948, No.1, pp. 93-122.
  • Vogl TJ, Helmberger TK, Mack MG, Reiser MF (eds). Percutaneous Tumor Ablation in Medical Radiology, Springer-Verlag, Berlin, Heidelberg, New York, 2008, 258 p.
  • Kennedy JE, ter Haar GR, Cranston D. High Intensity Focused Ultrasound: surgery of the future? Brit J Radiol, 2003, No. 76, pp. 590-599.
  • Hill CR, Rivens I, Vaughan M, et al. Lesion development in focused ultrasound surgery: a general model, Ultrasound Med Biol, 1994, No. 20, pp. 259-269.
  • Vaughan M, ter Haar G, Hill CR, et al. Minimally invasive cancer surgery using focused ultrasound: a pre-clinical, normal tissue study, Br J Radiol, 1994, No. 67, pp. 267-274.
  • Mason TJ. A sound investment. Chem Ind, 1998, pp. 878-882.
  • Hynynen K. The threshold for thermally significant cavitation in dogs’ thigh muscle in vivo, Ultrasound Med Biol, 1991, No. 17, pp. 157-169.
  • Wu F, Chen WZ, Bai J, et al. Tumor vessel destruction resulting from high-intensity focused ultrasound in patients with solid malignancies, Ultrasound Med Biol, 2002, No.28, pp. 535-542.
  • Delon-Martin C, Vogt C, Chignier E, et al. Venous thrombosis generation by means of high- intensity focused ultrasound, Ultrasound Med Biol, 1995, No. 21, pp.113-119.
  • Rivens BH, Rowland IJ, Denbow M, et al. Vascular occlusion using focused ultrasound surgery for use in fetal medicine, Eur J Ultrasound, 1999, No. 9, pp. 89-97.
  • Hynynen K, Chung A, Colucci V, et al. Potential adverse effects of high-intensity focused ultrasound exposure on blood vessels in vivo, Ultrasound Med Biol, 1996, No. 22, pp.193-201.
  • Vaezy S, Martin R, Kaczkowska P, et al. Use of high-intensity focused ultrasound to control bleeding, J Vase Surg, 1999, No.29, pp. 533-542.
  • Wu F, Chen WZ, Bai J, et al. Pathological changes in human malignant carcinoma treated with high-intensity focused ultrasound, Ultrasound Med Biol, 2001, No.27, pp. 1099-2006.
  • Chen L, Rivens I, ter Haar GR et al. Histological changes in rat liver tumours treated with high intensity focused ultrasound, Ultrasound Med Biol, 1993, No. 19, pp. 67-74.
  • Stewart EA, Gedroyc WM, Tempany CM, et al. Focused ultrasound treatment of uterine fibroid tumors: safety and feasibility of a noninvasive thermoablative technique, Am J Obstet Gynecol, 2003, No.189, pp. 48-54
  • Hynynen K, Pomeroy O, Smith DN et al. MR imaging-guided focused ultrasound surgery of fibroadenomas in the breast: A feasibility study, Radiology 2001, No. 219, pp. 176-185.
  • Gianfelice D, Khiat A, Boulanger Y, et al. Feasibility of magnetic resonance imaging-guided focused ultrasound surgery as an adjunct to tamoxifen therapy in high-risk surgical patients with breast carcinoma, J Vase Interv Radiol, 2003, No.14, pp. 1275- 1282.
  • Wu F, Wang ZB, Wang ZL, et al. Changes in ultrasonic image of tissue damaged by high intensity ultrasound in vivo, J Acoustic Soc Am, 1998, No. 103, pp. 2869.
  • Souchon R, Bouchoux G, Maciejko E, et al. Monitoring the formation of thermal lesions with heat-induced echo-strain imaging: a feasibility study, Ultrasound Med Biol, 2005, No.31, 251-259.
  • Jolesz FA, Hynynen K. Magnetic resonance image-guided focused ultrasound surgery, Cancer J, 2002, No.8, pp.100-112.
  • Vimeux FC, De Zwaet JA, Palussiere, et al. Real-time control of focused ultrasound heating based on rapid MR thermometry, Invest Radiol, 1999, No.34, 190-193.
  • Wu F, Wang ZB, Cao YD, et al. Changes in biologic characteristics of breast cancer treated with high-intensity focused ultrasound, Ultrasound Med Biol, 2003, No.29, pp.1487-1492.
  • Wu F, Wang ZB, Zhu H, et al. Extracorporeal high intensity focused ultrasound treatment for patients with breast cancer, Breast Cancer Research and Treatment, 2005, No.92, pp.51-60.